Cipher Pharmaceuticals Inc
TSX:CPH
Cipher Pharmaceuticals Inc
Inventory
Cipher Pharmaceuticals Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Inventory
$6.7m
|
CAGR 3-Years
43%
|
CAGR 5-Years
49%
|
CAGR 10-Years
20%
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Inventory
$1.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Inventory
CA$105.6m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
15%
|
|
|
Cronos Group Inc
TSX:CRON
|
Inventory
$48.2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Inventory
CA$144.4m
|
CAGR 3-Years
19%
|
CAGR 5-Years
18%
|
CAGR 10-Years
57%
|
|
Cipher Pharmaceuticals Inc
Glance View
Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. The company is headquartered in Oakville, Ontario. The company went IPO on 2004-02-25. The firm acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products directly in Canada and indirectly through partners in the United States, Canada and South America. Its Dermatology products include Actikerall, Epuris, Ozanex, and Vaniqa. Its Hospital Acute Care products are Aggrastat and Brinavess. The Company’s Out-Licensed Products include Absorica, ConZip, Durela, and Lipofen. The company is focused on three strategy that includes acquisitions, in-licensing, and selective investments in drug development to assemble a portfolio of prescription products that serve unmet medical needs. The firm's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC and Cipher Pharmaceuticals US LLC.
See Also
What is Cipher Pharmaceuticals Inc's Inventory?
Inventory
6.7m
USD
Based on the financial report for Sep 30, 2025, Cipher Pharmaceuticals Inc's Inventory amounts to 6.7m USD.
What is Cipher Pharmaceuticals Inc's Inventory growth rate?
Inventory CAGR 10Y
20%
Over the last year, the Inventory growth was 27%. The average annual Inventory growth rates for Cipher Pharmaceuticals Inc have been 43% over the past three years , 49% over the past five years , and 20% over the past ten years .
